Give Feedback
Showing 50 results
  • Innovation Watch

    Nov. 03, 2025
    Procurement teams seek to streamline sourcing and broader procurement to boost efficiency and value capture in the face of the various challenges such as macroeconomic uncertainties, supply chain volatilities, and geopolitical shocks that enterprises face today. Agentic AI, a configurable layer of autonomous agents, now makes it possible to generate content, derive insights, collaborate with humans-in-the-loop, invoke tools and APIs, and execute decisions end-to-end. Applied across S2P, agentic AI can triage intake, identify and qualify suppliers, assemble events and documentation, administer and monitor events, analyze proposals, support negotiation and awards, resolve PO/invoice exceptions with autonomous three-way match and fraud checks, enable guided tail-spend buying, and continuously sense third-party, ESG, and compliance risks. In this report, we examine agentic AI applications built for procurement and present detailed provider profiles, analyzing capabilities across procurement activities. The report is designed for procurement teams seeking to optimize sourcing and procurement through agentic AI by clarifying where to start and which solutions best fit their operating context.
  • Provider Compendium

    Aug. 22, 2025
    The increasing adoption of AI, generative AI, analytics, and industry-specific solutions across drug development, commercialization, and regulatory compliance is driving the rapid growth of digital services in the life sciences sector. Enterprises are turning to these technologies to improve operational resilience, accelerate time-to-market, and enhance customer and patient experiences. To meet this demand, providers are expanding their portfolios with domain expertise, industry-specific IP, data platforms, and centers of excellence, while also positioning themselves as end-to-end transformation partners by collaborating with enterprises to co-develop scalable solutions. This compendium provides detailed and fact-based snapshots of 35 life sciences digital service providers featured on Everest Group’s Life Sciences Digital Services PEAK Matrix®. Each provider profile offers a comprehensive view of its service focus, key IP/solutions, domain investments, and case studies. The study enables buyers to make informed sourcing decisions while allowing providers to benchmark themselves against competitors.
  • Viewpoint

    Aug. 20, 2025
    AI’s rapid evolution is revolutionizing the life sciences sector. After significant generative AI-enabled advances, enterprises are now witnessing the rise of agentic AI – autonomous systems capable of independent decision-making and action execution. However, many life sciences organizations grapple with legacy decision-making processes, fragmented data ecosystems, and innovation debt that hinder their competitive advantage. This report explores the strategic significance of agentic AI adoption, highlighting lessons learned from generative AI integration and detailing the unique opportunities and challenges associated with deploying autonomous AI systems. Key findings from industry surveys reveal gaps in readiness, data quality issues, regulatory complexities, and organizational readiness that enterprises must address. The report further delves into best practices to integrate agentic AI, including establishing robust governance frameworks, securing executive sponsorship, upskilling workforces, and conducting focused pilot programs. It highlights that leading organizations distinguish themselves by demonstrating the confidence to trust autonomous AI to drive outcomes once considered beyond reach.
  • Provider Compendium

    Aug. 19, 2025
    Life sciences enterprises are reassessing how they engage with healthcare professionals and patients amid growing emphasis on hybrid commercial models and personalized experiences. This shift is prompting greater interest in next-generation Customer Engagement Platforms (CEPs) that offer functionality beyond traditional systems, including real-time insights, dynamic content management, and omnichannel engagement. However, legacy systems, data silos, and fragmented customer experiences still pose challenges. To overcome these barriers, life sciences companies are partnering with specialized CEP providers to develop differentiated solutions that improve engagement, operational efficiency, and data-driven decision-making. In this report, we assess 27 next-generation CEP providers. The report enables buyers to choose the best-fit provider based on their sourcing considerations and empowers providers to benchmark themselves against their peers.
  • PEAK Matrix®

    July 31, 2025
    Life sciences enterprises are expanding their use of Veeva Vault across regulated functions, including clinical operations, regulatory information management, quality systems, promotional content management, and CRM. As adoption moves beyond single modules to integrated, cross-Vault deployments, the need for capable service partners has intensified. Enterprises are seeking providers that can support platform-led transformation, manage evolving compliance needs, and deliver automation and innovation at scale. This PEAK Matrix® report evaluates 35 providers delivering Veeva services across the global life sciences landscape. It assesses how these providers are enabling value realization through consulting, implementation, migration, maintenance, and accelerator-led delivery. By assessing providers across dimensions such as market adoption, innovation, and delivery footprint, the report helps enterprise buyers identify the right strategic partners for their Veeva services.
  • Webinar

    July 31, 2025
    Life sciences commercial teams are facing tighter budgets, faster launch cycles, and growing pressure to prove ROI from every investment and engagement. In this high-stakes environment, a new breed of specialist providers is stepping up, reshaping the commercial services landscape with targeted technology, therapeutic-area expertise, modular IP, and AI-enabled innovation designed for speed and precision. Unlike broad-based integrators, these specialists bring targeted solutions built for complexity in areas such as oncology, rare diseases, and specialty care, which is now essential. By blending therapeutic insights with smart tech and agile delivery, they’re helping sales, marketing, and launch teams move faster, make sharper decisions, and unlock value across the commercial value chain. Watch Everest Group experts as they explored how life sciences commercial services specialists are outpacing traditional integrators. As life sciences enterprises evaluate their provider portfolios, this session offered timely insights on how specialists compete – and often outperform – larger integrators on agility, depth, and commercial impact.
  • PEAK Matrix®

    June 09, 2025
    The life sciences industry is undergoing rapid digital transformation, fueled by the need for greater agility, regulatory compliance, and patient-centric operations. Enterprise platforms such as SAP, Oracle, and Salesforce have evolved from back-end systems of record to strategic innovation enablers, powering R&D, strengthening supply chains, and enhancing commercial effectiveness. However, challenges remain, as many organizations still operate fragmented legacy systems, struggle with complex migrations, and navigate the trade-offs between global standardization and local compliance. To address these needs, providers are investing in industry-specific accelerators, compliance-ready architectures, and intelligent automation capabilities. They are strengthening their expertise across SAP, Oracle, and Salesforce platforms, while also expanding AI/ML offerings to drive more proactive, insights-led operations. In this report, we assess 20 life sciences enterprise platform providers and position them on Everest Group’s PEAK Matrix®, a composite index of distinct metrics related to the providers’ capabilities and market impact. The study will enable buyers to choose the best-fit provider based on their sourcing considerations, while providers will be able to benchmark their performances against each other. Scope Industry: life sciences Geography: global Services: life sciences enterprise platform services Contents In this report, we examine: The provider landscape for life sciences enterprise platform services Life sciences enterprise platform providers on several capabilities and market success-related dimensions
  • Viewpoint

    June 06, 2025
    Procurement leaders today face multifaceted challenges marked by macroeconomic uncertainties, geopolitical turmoil, evolving regulations, cost pressures, and supply chain volatility. Amid these challenges, they are expected to optimize savings, manage supplier risks, ensure compliance, and meet sustainability goals – all while constrained by fragmented, reactive legacy systems. These legacy procurement systems fall short, often leading to reactive decisions, poor visibility, compliance lapses, and operational inefficiencies. This Viewpoint introduces Systems of Execution (SoE) as the next evolution for procurement: an intelligent, autonomous decision-execution framework orchestrating AI agents and operating seamlessly across the Source-to-Pay (S2P) value chain. By overlaying and embedding SoE capabilities into existing systems, procurement organizations can shift from static, reactive processes to dynamic, proactive workflows, enabling an intelligent, autonomous, agile, and execution-oriented procurement ecosystem. Scope All industries and geographies Contents In this report, we explore: SoE-led procurement transformation Functional transformation across the S2P value chain An implementation roadmap for procurement Strategic considerations for chief procurement officers
  • PEAK Matrix®

    June 02, 2025
    Life sciences enterprises are embracing digital technologies to navigate the growing complexities in drug development, commercialization, and regulatory compliance. As economic pressures and competitive dynamics intensify, organizations are turning to digital services to improve operational resilience and achieve faster time-to-market. Providers are responding with targeted investments in AI / generative AI, data platforms, and industry-specific solutions to meet enterprise demands across the life sciences value chain. This PEAK Matrix® report offers a detailed evaluation of 35 providers delivering digital services in the life sciences sector, including biopharmaceutical, medical device, and others. It examines how these providers are enabling transformation through scalable solutions, co-innovation models, and differentiated capabilities. By assessing providers across dimensions such as market adoption, innovation, and delivery footprint, the report helps enterprise buyers identify the right strategic partners for their digital agendas. Scope Industry: life sciences (biopharmaceutical, medical devices, and others) Service: digital services Geography: global Contents In this report, we offer: Providers’ evaluations The evaluation scope Market trends Provider landscape analysis Key buyer considerations and takeaways Memberships Life Sciences Information Technology Sourcing and Vendor Management
  • Webinar

    May 08, 2025
    As the outsourcing landscape evolves amid economic uncertainty, geopolitical changes, shifting buyer priorities, and rapid technological disruption, service providers must stay ahead of the curve to identify where the next wave of growth will come from. In this webinar, Everest Group experts unpacked key trends shaping the future of outsourcing. Backed by deep market data and analysis, the session explored how providers can navigate uncertainty, adapt to buyer behavior changes, and identify new pockets of growth. Attendees gained a clear view of market dynamics and walked away with practical insights to shape their growth strategies and stay ahead in an increasingly competitive landscape. What questions did the webinar answer? What’s changing in the global outsourcing industry, and how will it shape the future outlook? How is buyer behavior expected to change? How can providers maximize growth in a constrained environment? What are the emerging growth pockets?